Injectable nanoparticulate olanzapine formulations

Details for Australian Patent Application No. 2005307797 (hide)

Owner Elan Pharma International Ltd.

Inventors Jenkins, Scott; Liversidge, Gary

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005307797

PCT Pub. Number WO2006/055603

Priority 60/628,748 16.11.04 US

Filing date 16 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 2 June 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/055603 Priority application(s): WO2006/055603

2 June 2011 Application Accepted

  Published as AU-B-2005307797

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005307808-A method for single oxygen atom incorporation into digested peptides using peptidases

2005307790-Compositions, systems and methods for treatment of defects in blood vessels